| 2010 |
MICU1 (CBARA1) is a mitochondrial inner membrane-associated protein with two canonical EF hands required for mitochondrial Ca2+ uptake; RNAi silencing abolishes mitochondrial Ca2+ entry in intact and permeabilized cells without disrupting mitochondrial respiration or membrane potential, and attenuates metabolic coupling between cytosolic Ca2+ transients and matrix dehydrogenase activation. |
RNAi knockdown in intact and permeabilized cells, mitochondrial Ca2+ imaging, metabolic assays, subcellular fractionation |
Nature |
High |
20693986
|
| 2012 |
MICU1 interacts with the pore-forming MCU subunit and acts as a gatekeeper that sets a Ca2+ threshold for mitochondrial Ca2+ uptake without altering MCU kinetics; loss of MICU1 causes constitutive mitochondrial Ca2+ loading, excessive ROS generation, and sensitization to apoptotic stress. |
Co-immunoprecipitation (MICU1–MCU interaction), MICU1 knockdown, mitochondrial Ca2+ measurement, ROS assays, apoptosis assays |
Cell |
High |
23101630
|
| 2013 |
MICU1 faces the intermembrane space, establishes both the Ca2+ threshold and positive cooperativity (gain) of uniporter activation by sensing cytoplasmic [Ca2+] through its EF hands; loss of MICU1 causes mitochondrial Ca2+ accumulation at low [Ca2+]c but attenuated response to agonist-induced pulses. |
MICU1 loss-of-function in mouse liver and cultured cells, submitochondrial localization by protease protection/fractionation, mitochondrial Ca2+ imaging, EF-hand mutagenesis |
Cell Metabolism |
High |
23747253
|
| 2013 |
MICU1 and its paralog MICU2 reside within the same uniporter complex with MCU and cross-stabilize each other's protein expression; in vivo RNAi silencing of MICU1, MICU2, or both causes additive impairment of mitochondrial Ca2+ handling without affecting respiration or membrane potential. |
Co-immunoprecipitation, in vivo RNAi in mouse liver, Western blot, mitochondrial Ca2+ measurements |
PLoS One |
High |
23409044
|
| 2013 |
MICU1 localizes to the matrix side of the inner mitochondrial membrane; its N-terminal polybasic domain binds two coiled-coil domains of MCU; MICU1 forms homo-oligomers independently of the polybasic region, but the polybasic region confers oligomeric binding to MCU and controls mitochondrial Ca2+ current; EF hands regulate MCU channel activity but not MCU binding; loss of MICU1 increases oxidative burden and halts cell migration. |
Domain mapping by deletion/mutagenesis, Co-IP, mitoplast patch-clamp (IMCU), submitochondrial localization, cell migration assay |
Cell Reports |
High |
24332854
|
| 2014 |
MICU1 and MICU2 are nonredundant gatekeepers: knockout of either abolishes the normal [Ca2+] threshold for uniporter activity; MICU1/2 EF-hand mutants lacking Ca2+-binding cause striking loss of Ca2+ uptake (dominant negative), indicating they disinhibit the channel above threshold; MICU2's activity and physical association with MCU require MICU1, but not vice versa. |
CRISPR/Cas9 knockout of MICU1 or MICU2 in HEK-293T cells, EF-hand mutagenesis, Co-IP, mitochondrial Ca2+ measurements |
EMBO Reports |
High |
24503055
|
| 2015 |
Mia40/CHCHD4 oxidoreductase introduces an intermolecular disulfide bond linking MICU1 and MICU2 in a heterodimer; this disulfide bond is required for the MICU1-MICU2 dimer to associate with MCU at low Ca2+ and dissociate upon high Ca2+; absence of the disulfide bond results in increased receptor-induced mitochondrial Ca2+ uptake. |
Mia40 interactome screen, non-reducing SDS-PAGE to detect disulfide-linked heterodimer, Co-IP, mitochondrial Ca2+ measurements, Mia40 knockdown/overexpression |
Cell Metabolism |
High |
26387864
|
| 2015 |
Elevations of cytosolic Ca2+ rearrange MICU1 multimers with an EC50 of ~4.4 μM, resulting in MCU/EMRE activation; MICU1 rearrangement requires the EF-hand motifs and is strictly correlated with the shape of cytosolic Ca2+ rises, but is independent of matrix Ca2+ concentration, mitochondrial membrane potential, or MCU/EMRE expression levels. |
Live-cell FRET approach monitoring MICU1 multimer rearrangement, mitochondrial Ca2+ imaging |
Scientific Reports |
Medium |
26489515
|
| 2016 |
MICU1 deletion in mice causes perinatal lethality, ataxia, and muscle weakness with increased resting mitochondrial Ca2+, altered mitochondrial morphology, and reduced ATP; deleting one allele of EMRE in MICU1-/- mice normalizes Ca2+ uptake and rescues perinatal mortality, demonstrating that MICU1 counterbalances EMRE-enabled MCU activity in vivo. |
MICU1 knockout mouse model, EMRE heterozygous genetic rescue, mitochondrial Ca2+ measurements, ATP assays, behavioral phenotyping |
Cell Reports |
High |
27477272
|
| 2016 |
PRMT1 asymmetrically methylates MICU1, reducing its Ca2+ sensitivity; UCP2/3 normalize the Ca2+ sensitivity of methylated MICU1 to re-establish mitochondrial Ca2+ uptake activity, defining a post-translational regulatory axis that determines UCP2/3 dependency of mitochondrial Ca2+ uptake. |
PRMT1 overexpression/knockdown, methylation assays, UCP2/3 knockdown, mitochondrial Ca2+ measurements |
Nature Communications |
Medium |
27642082
|
| 2016 |
MICU1 knockout mice show accelerated Ca2+ overload-induced mitochondrial permeability transition pore opening in hepatocytes; MICU1 loss causes pro-inflammatory phase failure to resolve after partial hepatectomy, preventing liver regeneration via necrosis; PTP inhibition rescues regeneration. |
MICU1 KO mice, partial hepatectomy model, mitochondrial Ca2+ measurements, PTP inhibitor pharmacology, histology |
Nature Communications |
High |
26956930
|
| 2017 |
The MICU1:MCU protein stoichiometry directly controls tissue-specific uniporter phenotypes: low MICU1:MCU ratio (heart, skeletal muscle) lowers threshold and reduces cooperativity; overexpressing MICU1 in heart increases MICU1:MCU ratio, converts cardiac mitochondrial Ca2+ uptake to a liver-like phenotype, and causes cardiac contractile dysfunction. |
Quantitative Western blot of tissue MICU1:MCU ratios, MICU1 overexpression in heart, Co-IP demonstrating proportional MCU association, mitochondrial Ca2+ imaging, cardiac contractile function assays |
Cell Reports |
High |
28273446
|
| 2017 |
MICU1 overexpression activates pyruvate dehydrogenase (PDH) through the PDH phosphatase–phosphoPDH–PDH axis; in ovarian cancer cells, silencing MICU1 shifts metabolism from glycolysis to oxidative phosphorylation, inhibiting clonal growth, migration, and invasion, and increasing cisplatin efficacy in vivo. |
MICU1 siRNA knockdown and overexpression, PDH activity assay, lactate/oxygen consumption measurements, xenograft mouse model |
Nature Communications |
Medium |
28530221
|
| 2017 |
MICU2 regulates the threshold and gain of MICU1-mediated inhibition and activation of MCU; MICU1 alone mediates gatekeeping and cooperative MCU activation, while MICU2 tunes these parameters to spatially restrict Ca2+ crosstalk between single InsP3R and MCU channels. |
Whole-cell and mitoplast patch-clamp with quantitatively controlled [Ca2+]c, MICU1/MICU2 knockdown |
Cell Reports |
High |
29241542
|
| 2018 |
The mitochondrial import receptor Tom70 governs the mitochondrial translocation of MICU1; Tom70 deficiency reduces mitochondrial MICU1 levels, worsens Ca2+ overload and ischemia/reperfusion injury; Tom70 supplementation restores mitochondrial MICU1 and is cardioprotective only when MICU1 is present. |
siRNA knockdown and lentiviral overexpression of Tom70 and MICU1 in vivo, subcellular fractionation, mitochondrial Ca2+ measurement, MI/R mouse model |
Cell Death & Disease |
Medium |
28703803
|
| 2018 |
Parkin (PARK2) E3 ubiquitin ligase interacts with MICU1 and promotes its proteasomal degradation; Parkin's Ubl domain (not its E3 ligase activity) is required for MICU1 degradation; MICU1 is selectively degraded by the ubiquitin-proteasome system among MCU complex components; MICU2 stability is secondarily affected through loss of MICU1. |
Co-IP (Parkin–MICU1 interaction), Parkin overexpression/KD, proteasome inhibitor treatment, Parkin Ubl-domain mutagenesis, Western blot time-course |
Scientific Reports |
Medium |
30242232
|
| 2018 |
MICU1 interacts with the D-ring formed by the DIME selectivity filter motifs of MCU; a putative DIME-interacting domain (DID) in MICU1 is required for both gatekeeping and cooperative activation, and for cell survival; MICU1 suppresses inhibition of MCU by ruthenium red/Ru360 that bind the DIME motif. |
Mutagenesis of MICU1 DID, Ru360 inhibition assays, mitochondrial Ca2+ measurements, cell survival assays, Co-IP |
Molecular Cell |
High |
30454562
|
| 2019 |
The DIME-aspartate of MCU mediates a Ca2+-modulated electrostatic interaction with two conserved Arg residues of MICU1 and a nearby Ser at the cytoplasmic entrance of the MCU pore; perturbing these MCU-MICU1 interactions elicits constitutive, unregulated Ca2+ flux into mitochondria, indicating MICU1 gates the uniporter by blocking/unblocking the MCU pore. |
Mutagenesis screen of MICU1 and MCU DIME motif, mitochondrial Ca2+ flux assays, electrostatic interaction analysis |
eLife |
High |
30638448
|
| 2019 |
MICU1 is required for low [Ca2+]c gatekeeping in HEK cells but not in Trypanosoma cruzi; TcMICU1 knockout reduces mitochondrial Ca2+ uptake and impairs growth and host cell invasion, revealing lineage-specific adaptations of the MICU1 regulatory mechanism. |
CRISPR/Cas9 knockout of TcMICU1, mitochondrial Ca2+ uptake assays in permeabilized cells, growth and invasion assays |
mBio |
Medium |
31064825
|
| 2019 |
Crystal structure of MICU2 (apo form) at 2.5 Å reveals a core structure highly similar to MICU1 with two canonical Ca2+-binding and two structural EF-hands; a symmetrical dimer interface (EF1–EF3) is conserved between MICU1 and MICU2 homodimers, enabling exchange between homo- and heterodimers; MICU2's extended C-terminal helix is dispensable for MICU1 binding in vitro but required for MICU2 function in cells. |
X-ray crystallography (2.5 Å), in vitro binding assays, C-terminal helix deletion mutagenesis, cellular Ca2+ uptake assays |
PNAS |
High |
30755530
|
| 2019 |
MICU1 loss causes dysregulation of mitochondrial Ca2+ uptake during excitation-contraction coupling, aerobic metabolism impairment, muscle weakness, fatigue, and myofiber damage; additionally, MICU1 deficit compromises mitochondrial Ca2+ uptake during sarcolemmal injury, causing ineffective myofiber membrane repair. |
Skeletal muscle-specific MICU1 KO mice, patient cells, mitochondrial Ca2+ imaging during excitation-contraction, membrane repair assay, metabolic assays |
Cell Reports |
High |
31665639
|
| 2020 |
Cryo-EM structure of the MCU-EMRE-MICU1-MICU2 holocomplex at 3.3 Å shows that a uniporter interaction domain on MICU1 binds a channel receptor site comprising MCU and EMRE subunits, analogous to toxin block, to inhibit ion flow at resting Ca2+; a Ca2+-bound MICU1-MICU2 structure at 3.1 Å reveals how Ca2+-dependent conformational changes enable dynamic response to cytosolic Ca2+ signals. |
Cryo-EM structure determination (3.3 Å holocomplex; 3.1 Å Ca2+-bound MICU1-MICU2) |
eLife |
High |
32667285
|
| 2020 |
Inhibition of mitochondrial pyruvate or fatty acid transport increases MICU1 protein abundance (but not MCU) via transcription factor EGR1, thereby suppressing MCU-mediated matrix Ca2+ uptake and reducing resting matrix Ca2+; this defines a metabolic homeostatic circuit protecting cells from Ca2+ overload during nutrient stress. |
MPC isoform knockdown, dominant-negative MPC1R97W expression, MPC1 KO in hepatocytes and MEFs, EGR1 loss-of-function, mitochondrial Ca2+ measurements, MICU1 protein quantification |
Science Signaling |
Medium |
32317369
|
| 2022 |
Neuron-specific MICU1 KO mice show progressive motor and cognitive neurodegeneration caused by increased susceptibility to mitochondrial Ca2+ overload-induced excitotoxic insults and cell death; inhibiting the mitochondrial permeability transition pore blunts this neuronal death, establishing dysregulated neuronal mitochondrial Ca2+ homeostasis as causative. |
Neuron-specific MICU1 KO mouse, excitotoxicity assays, mPTP inhibitor pharmacological rescue, Ca2+ imaging, behavioral phenotyping |
Science Advances |
High |
35302860
|
| 2023 |
MICU1 localizes to the mitochondrial contact site and cristae organizing system (MICOS) independently of the MCU pore complex; MICU1 directly interacts with MICOS components MIC60 and CHCHD2; MICU1 ablation disrupts MICOS complex formation, alters cristae organization, mitochondrial ultrastructure, membrane dynamics, and cell death signaling—effects distinct from those seen with other mtCU subunit deficiencies. |
Proteomics, super-resolution imaging, Co-IP of MICU1 with MIC60 and CHCHD2, MICU1 KO mice and cells, electron microscopy |
Science Signaling |
High |
37098122
|
| 2023 |
Patch-clamp directly demonstrates that purified MICU1 strongly suppresses MCU Ca2+ currents; this inhibition is abolished by mutating MICU1's MCU-interacting K126 residue; a membrane-depolarization assay shows MICU1 prevents MCU-mediated Na+ flux into intact mitochondria in the absence of Ca2+, firmly establishing an occlusion/pore-blocking mechanism for MICU1 gating. |
Mitoplast patch-clamp with purified MICU1, K126 mutagenesis, membrane depolarization assay for Na+ flux, Ru265-sensitive current measurements |
PNAS |
High |
37036971
|
| 2023 |
MICU1 physically occludes the mtCU pore in divalent-free conditions: MICU1 KO cells show increased Ru265-sensitive Na+ influx and ensuing mitochondrial depolarization/swelling; excess acute MICU1 overexpression prevents this Na+ flux; some mtCU lack MICU1-dependent gating even in high-MICU1 cells, explaining prior conflicting results from mitoplast preparations. |
Fluorescence-based mitochondrial matrix [Na+] measurement, mitochondrial swelling/depolarization assay, MICU1 KO and rescue in HEK cells, Ru265 pharmacology |
PNAS |
High |
37126688
|
| 2023 |
MICU1 deficiency alters mitochondrial cristae junction structure through its interactions with MIC60 and CHCHD2 at the inner boundary membrane, leading to increased cytochrome c release, altered membrane potential, and changes in mitochondrial Ca2+ uptake dynamics. |
MICU1 KO cells, electron microscopy, Co-IP with MICOS components, cytochrome c release assay, Ca2+ imaging |
Cell Calcium |
Medium |
37290367
|
| 2024 |
MICU1 and MICU2 gate MCU in the beating mammalian heart; MICU1 is present in complex with MCU in nonfailing human hearts; MICU1 deletion alters cardiomyocyte mitochondrial Ca2+ signaling and energy metabolism; loss of MICU1 causes compensatory reduction in EMRE and later MCU abundance that limits Ca2+ uptake and permits cell survival. |
Murine cardiac MICU1 KO, Co-IP from human heart tissue, mitochondrial Ca2+ imaging, EMRE/MCU Western blot time-course, metabolic assays |
PNAS |
High |
39163336
|
| 2018 |
MICU1 confers selectivity of the uniporter by protecting against MCU-dependent Mn2+ uptake; MICU1 deletion sensitizes human cells to Mn2+-dependent cell death by disinhibiting MCU-mediated Mn2+ uptake and increasing oxidative stress, demonstrating MICU1's role in uniporter ion selectivity beyond Ca2+. |
Evolutionary co-occurrence analysis across 247 eukaryotes, yeast reconstitution of MCU/EMRE with/without MICU1 under Mn2+ stress, MICU1 KO in human cells, ROS assay, cell viability assay |
Cell Reports |
High |
30403999
|
| 2022 |
MICU1 deficiency in MICU1-/- cells activates SGPL1 (sphingosine phosphate lyase), which stimulates VPS39 recruitment to mitochondria, enhancing mitochondria-lysosome contacts; VPS39 downregulation compromises mitochondrial network maintenance and basal autophagic flux in MICU1-deficient cells. |
C. elegans micu-1 null mutant transcriptomics/proteomics, biochemical and imaging analysis in mammalian cells and mouse-derived tissues, VPS39 KD |
Molecular Metabolism |
Medium |
35452878
|
| 2022 |
RBFOX2 splicing factor drives alternative splicing of MICU1 pre-mRNA during myogenic differentiation, generating splice variants (including MICU1.1) with distinct mitochondrial Ca2+ uptake regulatory properties; human tissues express at least two additional MICU1 splice variants beyond the canonical form. |
RT-PCR characterization of splice variants in human tissues, RBFOX2 knockdown during myogenesis, mitochondrial Ca2+ uptake assays for each variant |
International Journal of Molecular Sciences |
Medium |
35269658
|
| 2018 |
FOXD1 transcription factor directly represses MICU1 expression in human embryonic stem cells and induced pluripotent stem cells; low MICU1 expression in hESCs/hiPSCs is due to Foxd1-mediated repression; restoration of MICU1 establishes periodic cytosolic Ca2+ oscillations and promotes cellular differentiation and maturation. |
MICU1 expression analysis in hESCs/hiPSCs, Foxd1 ChIP or reporter assays, MICU1 rescue experiments, Ca2+ imaging |
Nature Communications |
Medium |
30158529
|
| 2025 |
SIRT1 directly interacts with MICU1; SIRT1 inhibition reduces MICU1 expression, leading to mitochondrial Ca2+ overload and mitochondrial structural fragmentation, indicating SIRT1 regulates mitochondrial Ca2+ uptake at least partly through maintaining MICU1 levels. |
Co-IP (SIRT1–MICU1 interaction), SIRT1 pharmacological inhibition (EX527), shSIRT1 knockdown, mitochondrial Ca2+ imaging, mitochondrial morphology assessment |
Life (Basel) |
Low |
40003583
|